A Randomized-Controlled Trial of Inhaled Hypertonic Saline (7%) to Evaluate the Lung Clearance Index

NCT02276898 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Hypertonic Saline 7%
DRUG: Isotonic Saline 0.9% (Placebo)

Sponsor

The Hospital for Sick Children